These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33247185)

  • 1. Assessment of the hepatic tumor extracellular matrix using elastin-specific molecular magnetic resonance imaging in an experimental rabbit cancer model.
    Keller S; Borde T; Brangsch J; Reimann C; Kader A; Schulze D; Buchholz R; Kaufmann JO; Karst U; Schellenberger E; Hamm B; Makowski MR
    Sci Rep; 2020 Nov; 10(1):20785. PubMed ID: 33247185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elastin-specific MRI of extracellular matrix-remodelling following hepatic radiofrequency-ablation in a VX2 liver tumor model.
    Collettini F; Reimann C; Brangsch J; Chapiro J; Savic LJ; Onthank DC; Robinson SP; Karst U; Buchholz R; Keller S; Hamm B; Goldberg SN; Makowski MR
    Sci Rep; 2021 Mar; 11(1):6814. PubMed ID: 33767303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent Molecular Magnetic Resonance Imaging of Inflammatory Activity and Extracellular Matrix Degradation for the Prediction of Aneurysm Rupture.
    Brangsch J; Reimann C; Kaufmann JO; Adams LC; Onthank DC; Thöne-Reineke C; Robinson SP; Buchholz R; Karst U; Botnar RM; Hamm B; Makowski MR
    Circ Cardiovasc Imaging; 2019 Mar; 12(3):e008707. PubMed ID: 30871334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-probe molecular MRI for the in vivo characterization of atherosclerosis in a mouse model: Simultaneous assessment of plaque inflammation and extracellular-matrix remodeling.
    Reimann C; Brangsch J; Kaufmann JO; Adams LC; Onthank DC; Thöne-Reineke C; Robinson SP; Hamm B; Botnar RM; Makowski MR
    Sci Rep; 2019 Sep; 9(1):13827. PubMed ID: 31554825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy?
    Savic LJ; Doemel LA; Schobert IT; Montgomery RR; Joshi N; Walsh JJ; Santana J; Pekurovsky V; Zhang X; Lin M; Adam L; Boustani A; Duncan J; Leng L; Bucala RJ; Goldberg SN; Hyder F; Coman D; Chapiro J
    Radiology; 2020 Sep; 296(3):575-583. PubMed ID: 32633675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced magnetic resonance imaging evaluation of VX2 carcinoma in a rabbit model: comparison of 1.0-M gadobutrol and 0.5-M gadopentetate dimeglumine.
    Chang JM; Moon WK; Cha JH; Jung EJ; Cho N; Kim SJ
    Invest Radiol; 2010 Oct; 45(10):655-61. PubMed ID: 20808238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P03277-A New Approach to Achieve High-Contrast Enhancement: Initial Results of an Experimental Extracellular Gadolinium-Based Magnetic Resonance Contrast Agent.
    Fries P; Müller A; Seidel R; Robert P; Denda G; Menger MD; Schneider G; Buecker A
    Invest Radiol; 2015 Dec; 50(12):835-42. PubMed ID: 26186281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualization and Quantification of the Extracellular Matrix in Prostate Cancer Using an Elastin Specific Molecular Probe.
    Kader A; Brangsch J; Reimann C; Kaufmann JO; Mangarova DB; Moeckel J; Adams LC; Zhao J; Saatz J; Traub H; Buchholz R; Karst U; Hamm B; Makowski MR
    Biology (Basel); 2021 Nov; 10(11):. PubMed ID: 34827210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-Enhanced Magnetic Resonance Angiography Using a Novel Elastin-Specific Molecular Probe in an Experimental Animal Model.
    Reimann C; Brangsch J; Kaufmann JO; Adams LC; Onthank DC; Robinson SP; Botnar RM; Collettini F; Makowski MR
    Contrast Media Mol Imaging; 2018; 2018():9217456. PubMed ID: 30425609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Native T1 Mapping Magnetic Resonance Imaging as a Quantitative Biomarker for Characterization of the Extracellular Matrix in a Rabbit Hepatic Cancer Model.
    Keller S; Borde T; Brangsch J; Adams LC; Kader A; Reimann C; Gebert P; Hamm B; Makowski M
    Biomedicines; 2020 Oct; 8(10):. PubMed ID: 33066169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
    Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
    Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a Gadolinium-Based Nanoparticle (AGuIX) for Contrast-Enhanced MRI of the Liver in a Rat Model of Hepatic Colorectal Cancer Metastases at 9.4 Tesla.
    Fries P; Morr D; Müller A; Lux F; Tillement O; Massmann A; Seidel R; Schäfer T; Menger MD; Schneider G; Bücker A
    Rofo; 2015 Dec; 187(12):1108-15. PubMed ID: 26361379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modification of the method for preparing rabbit liver VX2 tumor model and its MRI findings].
    Quan XY; Xie W; Zhang XL; Sun XJ; Zhu XL; Yan Z; Liang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):747-9. PubMed ID: 16793590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
    Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
    Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental studies on artifacts and tumor enhancement on gadoxetic acid-enhanced arterial phase liver MRI in a rabbit VX2 tumor model.
    Tsuboyama T; Jost G; Kim T; Hori M; Onishi H; Pietsch H; Tomiyama N
    Acta Radiol; 2018 Sep; 59(9):1029-1037. PubMed ID: 29235879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of myocardial infarction and postinfarction scar remodeling with an elastin-specific magnetic resonance agent.
    Wildgruber M; Bielicki I; Aichler M; Kosanke K; Feuchtinger A; Settles M; Onthank DC; Cesati RR; Robinson SP; Huber AM; Rummeny EJ; Walch AK; Botnar RM
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):321-9. PubMed ID: 24363356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
    Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
    Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detectability of small liver metastases with gadolinium BOPTA.
    Runge VM; Lee C; Williams NM
    Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic Contrast-Enhanced MRI Using a Macromolecular MR Contrast Agent (P792): Evaluation of Antivascular Drug Effect in a Rabbit VX2 Liver Tumor Model.
    Park HS; Han JK; Lee JM; Kim YI; Woo S; Yoon JH; Choi JY; Choi BI
    Korean J Radiol; 2015; 16(5):1029-37. PubMed ID: 26357497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.